Brokerage house InCred Research has reiterated its bullish stance on India's equity markets, maintaining an Overweight view on the Nifty 50. This comes as the economy continues to surprise on the upside, driven by a sharp rebound in personal consumption, an upbeat festive season, and better-than-expected GDP data for Q2 FY26.
InCred has updated its high-conviction stock list for December 2025, highlighting strategic portfolio adjustments and key opportunities across large-caps, mid-caps, and small-caps. The removal of Shriram Finance from its high-conviction basket is the headline change, following a 28% gain over the last two months.
InCred's conviction list includes established leaders with strong earnings visibility. Some of the top picks include:
Among mid-caps, InCred highlights Container Corporation of India (Concor) with 53.2% upside, Apollo Tyres with 9.4% upside, and Ajanta Pharma with 18.9% upside. In the small-caps category, Deepak Fertilisers (ADD) offers a robust 56.6% upside, while Thyrocare Technologies (ADD) has a standout 223% upside potential.
InCred highlights that India's Q2 FY26 GDP growth of 8.2% significantly exceeded expectations, supported by strong private consumption growth of 7.9%. However, the brokerage cautions that rupee depreciation remains a concern, even as domestic drivers such as government spending and consumption revival help offset external pressures.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Download the TradeKaizen app to practice F&O trading with real-time market data anytime, anywhere.
Get it on Google PlayConnect with fellow traders, share strategies, and improve your trading skills in our Telegram group.
Join Telegram